| abstract |
Roflumilast N-oxide or a pharmaceutically acceptable salt thereof having a d50 of less than about 6 microns and a d90 (i) equal to or less than about 10 microns (ii) less than about 6 microns, or (iii) between about 1 and about 6 microns, for use in treating an autoimmune, respiratory or inflammatory disease or condition in a subject in need thereof, comprising pulmonary administration in an effective amount. |